ECS Botanics Holdings Ltd (ASX:ECS)
Australia · Delayed Price · Currency is AUD 0.0050
-0.0005 (-9.09%)
Oct 1, 2026, 3:54 PM AEST
ECS Botanics Holdings Revenue
In the fiscal year ending June 30, 2026, ECS Botanics Holdings had annual revenue of 21.02M AUD with 8.55% growth. ECS Botanics Holdings had revenue of 9.68M in the half year ending June 30, 2026, with 10.63% growth.
Revenue
21.02M
Revenue Growth
+8.55%
P/S Ratio
0.42
Revenue / Employee
n/a
Employees
n/a
Market Cap
8.81M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 21.02M | 1.66M | 8.55% |
| Jun 30, 2025 | 19.36M | -667.21K | -3.33% |
| Jun 30, 2024 | 20.03M | 4.64M | 30.16% |
| Jun 30, 2023 | 15.39M | 10.09M | 190.43% |
| Jun 30, 2022 | 5.30M | 3.92M | 285.34% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vitura Health | 131.16M |
| Medical Developments International | 42.57M |
| IDT Australia | 20.38M |
| Elixinol Wellness | 15.90M |
| Epsilon Healthcare | 13.58M |
| Peak Processing | 12.51M |
| Cann Group | 9.65M |
| Syntara | 6.93M |